DBV TECHNOLOGIES S A DBVT
SPONSORED ADS · ADR · CUSIP 23306J309
Publicly owned French biopharmaceutical firm headquartered in Bagneux, France
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersBagneux, France
- Founded2002
- Websitedbv-technologies.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($264.1k this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $20.47. Options: 1 managers hold calls ($146.2k notional), 0 hold puts (—).
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2024 | 19 |
| Q1 2025 | 17 |
| Q2 2025 | 30 |
| Q3 2025 | 33 |
| Q4 2025 | 52 |
| Q1 2026 | 71 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2025 | 7 | 6 |
| Q2 2025 | 19 | 6 |
| Q3 2025 | 15 | 10 |
| Q4 2025 | 40 | 11 |
| Q1 2026 | 42 | 23 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q2 2025 | $0 | $0 | — |
| Q3 2025 | $0 | $0 | — |
| Q4 2025 | $0 | $0 | — |
| Q1 2026 | $146.2k | $0 | 0.00 |
Biggest buyers
| MPM BIOIMPACT LLC | Added | +4.2m |
| ADAR1 Capital Management, LLC | New | +1.0m |
| PERCEPTIVE ADVISORS LLC | New | +964.4k |
| Duquesne Family Office LLC | New | +383.4k |
| Patient Square Capital LP | Added | +334.5k |
| Elmind Capital, LP | New | +265.0k |
| AMERIPRISE FINANCIAL INC | New | +231.4k |
| Vivo Capital, LLC | Added | +205.9k |
| Russell Investments Group, Ltd. | New | +128.6k |
| Dorsey Wright & Associates | New | +102.5k |
Biggest sellers
| Artisan Partners Limited Partnership | Reduced | -1.1m |
| Yiheng Capital Management, L.P. | Reduced | -469.6k |
| Schonfeld Strategic Advisors LLC | Sold out | -454.3k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -321.9k |
| Vestal Point Capital, LP | Sold out | -300.0k |
| Squadron Capital Management LLC | Sold out | -240.0k |
| UBS Group AG | Reduced | -165.3k |
| CITADEL ADVISORS LLC | Sold out | -145.1k |
| Redmile Group, LLC | Reduced | -58.5k |
| NEW YORK STATE COMMON RETIREMENT FUND | Reduced | -55.0k |
Biggest calls
| Brooklands Fund Management Ltd | New | $146.2k7.0k shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
BAKER BROS. ADVISORS LP
13D · may seek influence
-7.1 pts · filed 2026-01-14
Stated purposeItem 4 of Schedule 13D is supplemented and amended, as the case may be, as follows: On January 12, 2026, 667 and Life Sciences exercised 2,299,656 and 25,005,240 warrants, respectively, (each, a "BS Warrant") of the Issuer, at a strike price of EUR 1.5764, on a one-for-one basis into pre-funded warrants (each, a "Second Pre-Funded Warrant"), each of which are exercisable for 1.75 Ordinary Shares of the Issuer at an exercise price of EUR 0.0175. The BS Warrants were exercisable until January 15, 2026, which is 30 days following the publication by the Issuer that the VITESSE Phase 3 study met its primary endpoint as further described in the Terms and Conditions of the BS Warrants. Each of the Funds paid the exercise price for the BS Warrants using its working capital. The Second Pre-Funded… Full filing |
10.0% |
| SUVRETTA CAPITAL MANAGEMENT, LLC 13G · passive investor new · filed 2025-04-11 | 9.9% |
| JANUS HENDERSON GROUP PLC 13G · institution +6.2 pts · filed 2026-01-08 | 8.8% |
| Adage Capital Management, L.P. 13G · institution -2.7 pts · filed 2026-05-13 | 7.3% |
| Invus Global Management, LLC 13G · passive investor +0.3 pts · filed 2026-05-05 | 6.5% |
| CITADEL ADVISORS LLC 13G · passive investor new · filed 2025-04-14 | 6.4% |
| MPM BioImpact LLC 13G · institution -2.6 pts · filed 2026-08-14 | 6.2% |
| RA CAPITAL MANAGEMENT, L.P. 13G · passive investor new · filed 2026-08-06 | 5.8% |
Fell to 5% or below in the last year: Artisan Partners Limited Partnership (3.7%, 2026-05-13), Vivo Opportunity Fund Holdings, L.P. (4.0%, 2026-05-12), Venrock Healthcare Capital Partners II, L.P. (0.0%, 2026-02-17), Bpifrance Participations SA (4.7%, 2026-01-07)
Insider purchases and sales in Q1 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q2 2024 | 0 | — | 1 | $1.4k | — |
| Q3 2024 | 0 | — | 1 | — | — |
| Q4 2024 | 0 | — | 1 | — | — |
| Q1 2025 | 0 | — | 1 | — | — |
| Q2 2025 | 0 | — | 1 | $730 | — |
| Q3 2025 | 0 | — | 1 | — | — |
| Q4 2025 | 0 | — | 1 | — | — |
| Q1 2026 | 0 | — | 1 | $2.6k | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2026-01-29 | Mohideen Pharis Chief Medical Officer | Sold | $2.6k534 shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q1 2026
| Manager | Shares | Change |
|---|---|---|
| MPM BIOIMPACT LLC 8.41% of their portfolio | 5.2m $108.9m | Added +4.2m |
| Vivo Capital, LLC 4.63% of their portfolio | 2.7m $55.7m | Added +205.9k |
| Artisan Partners Limited Partnership 0.08% of their portfolio | 2.2m $46.4m | Reduced -1.1m |
| Siren, L.L.C. 1.08% of their portfolio | 1.9m $38.8m | Unchanged |
| BAKER BROS. ADVISORS LP 0.18% of their portfolio | 1.5m $30.5m | Unchanged |
| ADAR1 Capital Management, LLC 1.27% of their portfolio | 1.0m $21.2m | New |
| PERCEPTIVE ADVISORS LLC 0.40% of their portfolio | 964.4k $20.1m | New |
| Patient Square Capital LP 2.57% of their portfolio | 693.5k $14.5m | Added +334.5k |
| Octagon Capital Advisors LP 1.33% of their portfolio | 574.2k $12.0m | Unchanged |
| Ikarian Capital, LLC 0.31% of their portfolio | 525.0k $2.2m | Unchanged |
| Redmile Group, LLC 0.68% of their portfolio | 491.3k $10.3m | Reduced -58.5k |
| Duquesne Family Office LLC 0.27% of their portfolio | 383.4k $8.0m | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 319.0k $6.7m | Reduced -321.9k |
| Atika Capital Management LLC 0.89% of their portfolio | 271.3k $5.7m | Added +64.4k |
| Elmind Capital, LP 1.57% of their portfolio | 265.0k $5.5m | New |
| Balyasny Asset Management L.P. 0.01% of their portfolio | 233.4k $4.9m | Reduced -1.6k |
| AMERIPRISE FINANCIAL INC 0.00% of their portfolio | 231.4k $4.8m | New |
| Yiheng Capital Management, L.P. 1.54% of their portfolio | 170.1k $3.6m | Reduced -469.6k |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 168.2k $3.5m | Reduced -55.0k |
| BOOTHBAY FUND MANAGEMENT, LLC 0.08% of their portfolio | 163.4k $3.4m | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 146.1k $3.1m | Added +23.6k |
| Russell Investments Group, Ltd. 0.00% of their portfolio | 128.6k $2.7m | New |
| Dorsey Wright & Associates 0.27% of their portfolio | 102.5k $2.1m | New |
| Ishara Investments LP 2.16% of their portfolio | 102.5k $2.1m | New |
| ENVESTNET ASSET MANAGEMENT INC 0.00% of their portfolio | 95.7k $2.0m | Added +73.3k |
| UBS Group AG 0.00% of their portfolio | 79.5k $1.7m | Reduced -165.3k |
| Polymer Capital Management (HK) LTD 0.19% of their portfolio | 64.5k $1.3m | Unchanged |
| DIVERSIFY WEALTH MANAGEMENT, LLC 0.02% of their portfolio | 63.7k $1.3m | New |
| LPL Financial LLC 0.00% of their portfolio | 55.9k $1.2m | New |
| AdvisorShares Investments LLC 0.19% of their portfolio | 50.3k $1.1m | New |
| XTX Topco Ltd 0.02% of their portfolio | 42.1k $878.5k | New |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 37.4k $781.9k | Added +23.7k |
| NAN FUNG TRINITY (HK) LTD 0.09% of their portfolio | 37.1k $774.9k | Unchanged |
| Engineers Gate Manager LP 0.01% of their portfolio | 33.0k $690.2k | Added +8.1k |
| STIFEL FINANCIAL CORP 0.00% of their portfolio | 30.7k $642.1k | New |
| Cetera Investment Advisers 0.00% of their portfolio | 25.4k $529.7k | Added +12.2k |
| HRT FINANCIAL LP 0.00% of their portfolio | 24.1k $503.0k | New |
| Burns Matteson Capital Management, LLC 0.18% of their portfolio | 22.6k $472.8k | New |
| Atria Investments, Inc 0.00% of their portfolio | 21.1k $441.5k | New |
| Optiver Holding B.V. 0.02% of their portfolio | 19.0k $397.9k | Reduced -28.7k |
| SEI INVESTMENTS CO 0.00% of their portfolio | 16.8k $350.2k | Reduced -49.6k |
| PERSONAL CFO SOLUTIONS, LLC 0.04% of their portfolio | 12.6k $264.1k | New |
| ExodusPoint Capital Management, LP 0.00% of their portfolio | 11.5k $241.0k | Reduced -15.7k |
| Persistent Asset Partners Ltd 0.09% of their portfolio | 11.4k $238.0k | Added +5.4k |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 11.3k $235.7k | New |
| Integrated Wealth Concepts LLC 0.00% of their portfolio | 10.6k $221.1k | New |
| BARCLAYS PLC 0.00% of their portfolio | 8.1k $168.8k | New |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 6.1k $127.4k | Reduced -334 |
| China Universal Asset Management Co., Ltd. 0.01% of their portfolio | 5.0k $104.5k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 4.7k $98.0k | Added +2.9k |
| Truvestments Capital LLC 0.01% of their portfolio | 3.9k $81.3k | Unchanged |
| GAMMA Investing LLC 0.00% of their portfolio | 2.9k $60.6k | Added +219 |
| Allworth Financial LP 0.00% of their portfolio | 1.7k $35.2k | Unchanged |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 1.1k $23.4k | Added +778 |
| HM PAYSON & CO 0.00% of their portfolio | 420 $8.8k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 300 $6.3k | Unchanged |
| HARBOUR INVESTMENTS, INC. 0.00% of their portfolio | 259 $5.4k | New |
| Ascentis Wealth Management, LLC 0.00% of their portfolio | 259 $5.4k | New |
| Farther Finance Advisors, LLC 0.00% of their portfolio | 164 $3.4k | New |
| Federation des caisses Desjardins du Quebec 0.00% of their portfolio | 145 $3.0k | Unchanged |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.00% of their portfolio | 111 $2.3k | Unchanged |
| Caitong International Asset Management Co., Ltd 0.00% of their portfolio | 67 $1.4k | New |
| Pinnacle Wealth Planning Services, Inc. 0.00% of their portfolio | 40 $836 | Unchanged |
| Advisory Services Network, LLC 0.00% of their portfolio | 30 $627 | New |
| CURIO WEALTH, LLC 0.00% of their portfolio | 27 $564 | Unchanged |
| Bell Investment Advisors, Inc 0.00% of their portfolio | 21 $439 | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 20 $391 | Reduced -28.4k |
| EverSource Wealth Advisors, LLC 0.00% of their portfolio | 14 $292 | Reduced -465 |
| TRUST CO OF TOLEDO NA /OH/ 0.00% of their portfolio | 10 $209 | Unchanged |
| BlackRock, Inc. 0.00% of their portfolio | 2 $42 | Unchanged |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 1 $21 | New |